Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.20.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 121
Operating expenses:        
Research and development 8,030 9,276 26,364 27,434
Selling, general and administrative 3,481 2,480 9,448 7,501
Total operating expenses 11,511 11,756 35,812 34,935
Loss from operations (11,511) (11,756) (35,812) (34,814)
Other (income) expense:        
Loss on extinguishment of debt 0 0 806 1,045
Amortization of debt issuance costs and discount 311 306 910 879
Interest income (5) (170) (188) (680)
Interest expense 330 203 859 774
Other income 0 0 (386) 0
Other expense 20 0 602 0
Warrant liabilities fair value adjustment (7,786) (1,830) (16,114) 2,643
Derivative liabilities fair value adjustment (5,290) (2,324) (6,683) (223)
Total other (income) expense (12,420) (3,815) (20,194) 4,438
Income (loss) before taxes 909 (7,941) (15,618) (39,252)
Income tax benefit 0 0 (3,144) 0
Net income (loss) $ 909 $ (7,941) $ (12,474) $ (39,252)
Net income (loss) per share attributable to common stockholders – basic        
Net income (loss) per share – basic $ 0.09 $ (1.43) $ (1.23) $ (7.44)
Net loss per share attributable to common stockholders – diluted        
Net loss per share – diluted $ (0.28) $ (1.45) $ (1.37) $ (7.44)
Weighted average common shares outstanding – basic and diluted        
Basic 10,627,618 5,569,739 10,129,098 5,278,757
Diluted 13,389,014 6,707,939 11,220,802 5,278,757